Belvedere Trading’s Insmed INSM Stock Holding History

Belvedere Trading’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,200	Closed	-$482K	–	803
2024 Q2	$482K	Sell	7,200 -700	-9%	-$27.1K	﹤0.01%	193
2024 Q1	$214K	Buy	+7,900	New	+$221K	﹤0.01%	324

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Belvedere Trading's INSM Position: Q3 2024 in Review

Belvedere Trading sold out of Insmed (INSM) in Q3 2024, closing a stake of 4,624 shares — an estimated $310K sold.

Belvedere Trading first reported a position in INSM in Q3 2023 and held it in 3 quarters. The position peaked at $477K in Q1 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

Belvedere Trading reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
Belvedere Trading sold 4,624 Insmed shares in Q3 2024, an estimated $310K.
Belvedere Trading first reported a position in Insmed in Q3 2023 and held it in 3 quarters.
Belvedere Trading's Insmed position peaked at $477K in Q1 2024.
413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Belvedere Trading's 13F filing for Q3 2024, filed 30 Oct 2024.